Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo.

Chitosan vector system is expected to be useful for direct gene therapy for joint disease. This study first sought to confirm that foreign genes can be transferred to articular chondrocytes in primary culture. Next, chitosan-DNA nanoparticles containing IL-1Ra or IL-10 gene were injected directly into the knee joint cavities of osteoarthritis rabbits to clarify the in vivo transfer availability of the chitosan vectors. Clear expression of IL-1Ra was detected in the knee joint synovial fluid of the chitosan IL-1Ra-injected group. While no expression was detected in the chitosan IL-10-injected group, this demonstrates that the transfection efficiency of chitosan-DNA nanoparticles was closely related to the type of the gene product. A significant reduction was also noted in the severity of histologic cartilage lesions in the group that received the chitosan IL-1Ra injection. This avenue may therefore represent a promising future treatment for osteoarthritis.

[1]  Ronald G. Crystal,et al.  The gene as the drug , 1995, Nature Medicine.

[2]  Antonios G Mikos,et al.  Advances in drug delivery for articular cartilage. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[3]  M. Sheppard,et al.  In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. , 1999, The American journal of pathology.

[4]  L. Seymour,et al.  Key issues in non-viral gene delivery: Adv Drug Deliv Rev , 1998 .

[5]  A. Rolland,et al.  Target Specific Optimization of Cationic Lipid-Based Systems for Pulmonary Gene Therapy , 1998, Pharmaceutical Research.

[6]  R. Mumper,et al.  Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[7]  D. Zukor,et al.  Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. , 2005, Arthritis and rheumatism.

[8]  J. Bonadio,et al.  Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. , 1995, The Journal of clinical investigation.

[9]  A. Chan,et al.  Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. , 2003, Biochimica et biophysica acta.

[10]  J. Pelletier,et al.  In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. , 1997, Arthritis and rheumatism.

[11]  Y. Hirasawa,et al.  Adenovirus mediated gene delivery to the joints of guinea pigs. , 1998, The Journal of rheumatology.

[12]  L. Seymour,et al.  Key issues in non-viral gene delivery. , 1998, Advanced drug delivery reviews.

[13]  J. Pelletier,et al.  Cytokines and their role in the pathophysiology of osteoarthritis. , 1999, Frontiers in bioscience : a journal and virtual library.

[14]  U. Bakowsky,et al.  Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents. , 2004, Journal of nanoscience and nanotechnology.

[15]  C. McIlwraith,et al.  Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene , 2002, Gene Therapy.

[16]  Y. Okahata,et al.  Mechanism of cell transfection with plasmid/chitosan complexes. , 2001, Biochimica et biophysica acta.

[17]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[18]  J. Saklatvala Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage , 1986, Nature.

[19]  R. Mumper,et al.  Novel polymeric condensing carriers for gene delivery , 1995 .

[20]  Y. Machida,et al.  Biodegradation and distribution of water-soluble chitosan in mice. , 1999, Biomaterials.

[21]  Lisbeth Illum,et al.  Chitosan as a Novel Nasal Delivery System for Peptide Drugs , 1994, Pharmaceutical Research.

[22]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[23]  T. Bettinger,et al.  Chitosan-Based Vector/DNA Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability , 1998, Pharmaceutical Research.

[24]  M. Takigawa,et al.  Direct adenovirus-mediated gene delivery to the temporomandibular joint in guinea-pigs. , 1999, Archives of oral biology.

[25]  J. Lowe,et al.  Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. , 1997, Journal of pharmaceutical sciences.

[26]  James M. Wilson,et al.  Methods of gene delivery. , 1998, Hematology/oncology clinics of North America.

[27]  J. Haskill,et al.  Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats. , 1995, Gene therapy.

[28]  C. P. Sharma,et al.  Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. , 1997, Journal of biomedical materials research.

[29]  I. Verma,et al.  Gene therapy - promises, problems and prospects , 1997, Nature.

[30]  K. Leong,et al.  DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[31]  R. Gay,et al.  Gene therapy in osteoarthritis. , 2000, Joint, bone, spine : revue du rhumatisme.

[32]  E. Terwilliger,et al.  Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. , 2003, Human gene therapy.

[33]  R. Lockey,et al.  Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo. , 2004, Journal of nanoscience and nanotechnology.

[34]  L. Bonassar,et al.  Detection of interleukin-1 in the cartilage of patients with osteoarthritis: a possible autocrine/paracrine role in pathogenesis. , 1997, Osteoarthritis and cartilage.

[35]  M. Billah,et al.  IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. , 1994, Journal of immunology.

[36]  Y Wang,et al.  Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[37]  R. Duncan,et al.  Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. , 1999, International journal of pharmaceutics.

[38]  Y Ikada,et al.  In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. , 1997, Biomaterials.